Navigation Links
Brazilian Boost for Bird Flu Vaccines

Brazilian scientists have developed a modifying agent which could make vaccines for the H5N1 bird flu virus cheaper, more effective, and easier to produce//.

The development could help developing countries at the forefront of any bird flu pandemic struggling to access and afford the vaccines and drugs produced and stockpiled by developed countries.

Researchers from the Butantan Institute, based in S?o Paulo, Brazil, claim that an adjuvant called Monophosphoryl Lipid A (MPLA) was effective in boosting the immune response to strains of Vietnamese and Indonesian avian flu virus in mice.

An adjuvant is a chemical substance that boosts a vaccine's effectiveness by increasing its ability to stimulate the immune system.

According to Isaías Raw, director of the institute, MPLA reduced the amount of antigen — virus protein — needed to cause an immune response to one quarter of that previously required, reducing the cost of vaccine production.

Raw says were a pandemic to occur now, the adjuvant would enable 80–100 million doses of seasonal flu vaccine to be produced by the end of April.

Clinical trials in humans are planned, with results expected at the end 2008.

John Oxford, scientific director of Retroscreen Virology Ltd and professor of virology at UK-based Queen Mary's School of Medicine and Dentistry, said the adjuvant "looks to be a most interesting and practical step forward that will be needed in the face of a pandemic."

He also stressed the importance of increased hygiene and isolation procedures as well as the building a stockpile of antiviral drugs.

Marie-Paule Kieny, director of the World Health Organization (WHO) Initiative for Vaccine Research, cautioned that results were still only available for mice and that it was too early to assess the vaccine's effectiveness in humans.

But she welcomed the development and said the WHO had initiated colla
'"/>




Page: 1 2 3

Related medicine news :

1. Brazilian Women to Be Vaccinated To Prevent Uterine Cancer
2. Hepatitis G May Boost HIV Survival
3. Drug Combinations May Boost Stroke Risk
4. Reduced Fatigue Boosts Mental Health
5. Therapy Boosts Chemotherapy Effects
6. Need for Hepatitis Booster Questioned
7. Vasopressin Found To Boost Survival In Sudden Cardiac arrest
8. Exercising To Music Found To Boost Brain Power
9. Consuming Fish During Pregnancy Boosts Child’s I
10. Vitamin Supplements During Pregnancy to Boost Fetal Development
11. Immune Boost With LHRH To Help Cancer And Transplant Patients
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Brazilian Boost for Bird Flu Vaccines

(Date:1/7/2009)...ed at 37 weeks have double the troubles of those b...althDay News) -- Women having an elective repeat C...ks into their pregnancy to have the baby, if there...new study found. , Delivering just two weeks earl...ems, such as trouble breathing, infection and low ...
(Date:1/7/2009)...hows 73 Percent Increase in Patients Unable to Pay... Patients Visiting Hospital ERs , , SACRAMENTO, C...the nation is having a dramatic impact on Californ...eased special report by the California Hospital As...on a survey conducted in November 2008 among hospi...
(Date:1/7/2009)...TER, Ill., Jan. 7 BrainLAB, Inc., a leader in,sof...edical treatments,announces a new, customer-focuse... consideration of continued growth and an expandin...les and support structures, customers will benefit...zation. Streamlined,responsibilities, communicatio...
(Date:1/7/2009)...Ore., Jan. 7 Synthetech, Inc.,(OTC Bulletin Board...rovement,Awards for their outstanding accomplishme...& Security (EHS&S) Planning and Operations...ds are presented by the Synthetic Organic,Chemical...y ChemStewards,SOCMA,s EHS&S improvement initi...
Breaking Medicine News(10 mins):Health News:Early Elective C-Sections Produce Complications 2Health News:Early Elective C-Sections Produce Complications 3Health News:Economic Downturn Takes Toll on California Hospitals 2Health News:BrainLAB, Inc. Announces New, Streamlined Surgery Business Division 2Health News:Synthetech Earns National Recognition for Performance Improvement Program 2Health News:Synthetech Earns National Recognition for Performance Improvement Program 3
...17 packets of counterfeit condoms of Durex best-se...n by British authorities.// A Durex spokeswoman s...fety' of the fakes. The number of these fakes that...These counterfeits came to light only after three ...
...A vaccine which could protect children from mening...in Perth. Until now immunization against the disea...om the Vaccine Trials Group at the Telethon Instit...cess Margaret Hospital for Children, hope that th...
...Medicins Sans Frontiers(MSF), on Monday called for...s which are likely to be effective against extreme...highly prevalent, especially in sub Saharan Africa...t Borders(DWB) has urged that the regulatory bodie...
...Long trusted Turmeric the must have spice in every...h western scientists raving about its potential us...erative disorders thus vindicating the claims of s...of Ayurveda. According to a recent study conducte...
Other Medicine News:Health News:Faster Approval Procedures Urged For New TB Drugs 2
(Date:1/7/2009)...-- ImQuest Life Sciences announced today the succe... and Drug Administration to initiate human clinica...tor IQP-0410. ImQuest anticipates initiating their...-0410 is a novel small molecule inhibitor of HIV w...nscriptase inhibitor (NNRTI). The compound possess...
(Date:1/6/2009)...s from prior U.S., U.K. and China Trials , , SA...nc. (VTI), a development stage company targeting l...as begun for a randomized, controlled, multi-cente...acorporeal Liver Assist Device (ELAD) as a treatme...er three protocols. The study is open for enrollme...
(Date:1/6/2009)...SNewswire/ -- Sequella, Inc., a clinical-stage bio...emic potential, announced today that SQ109, its le...s (TB), was the first drug approved for evaluation...ynport Vaccine Company LLC and Quintiles Transnati...ute of Allergy and Infectious Diseases (NIAID), Na...
(Date:1/5/2009)...lene Pharmaceuticals announced today that it has i...protein kinase inhibitor, CX-4945, in patients wit...ultiple myeloma. The primary endpoints of the oral..., tolerance and PK properties of CX-4945 and to se...addition, multiple mechanism-related pharmacodynam...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3National Cancer Registrars Association and IMPAC Medical Systems Announce Best Paper Award Recipients 5035 1National Cancer Registrars Association and IMPAC Medical Systems Announce Best Paper Award Recipients 5035 2National Cancer Registrars Association and IMPAC Medical Systems Announce Best Paper Award Recipients 5035 3Richard A Schatz M D Joins Cardiums Scientific Advisory Board 5032 1Richard A Schatz M D Joins Cardiums Scientific Advisory Board 5032 2Richard A Schatz M D Joins Cardiums Scientific Advisory Board 5032 3Richard A Schatz M D Joins Cardiums Scientific Advisory Board 5032 4Rutgers research partner Stemcyte Inc expands to New Jersey 18164 1Rutgers research partner Stemcyte Inc expands to New Jersey 18164 2Go Speed Racer 21 Revving up the worlds fastest nanomotors 18161 1
... Rheumatoid Factor IgM enzyme linked immunosorbent...(RF IgM). Enzyme-linked immunosorbent assay method...M Rheumatoid Factor in human serum. The results of...gnosis of Rheumatoid Arthritis when supported by o...
Rheumatoid Factor , R1: 4 X 20 ml buffer, R2: 2 X 8 ml antibody, Test / Kit: 320 (H717)
...r is a high precision optical system for corneal t...terior eye segment, based on a Revolving Dual Chan...GALILEI combines the advantages of two technologie...re data, while Scheimpflug imaging is optimal for ...
EXTEND is an absorbable synthetic punctal implant that provides occlusion up to three months. It is packaged 20 implants per box in sizes of .0.3mm, 0.4mm, 0.5mm. A variety pack in also available w
Medicine Products: